###begin article-title 0
Asthma families show transmission disequilibrium of gene variants in the vitamin D metabolism and signalling pathway
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 49 54 <span type="species:ncbi:9606">women</span>
The vitamin D prophylaxis of rickets in pregnant women and newborns may play a role in early allergic sensitization. We now asked if an already diseased population may have inherited genetic variants in the vitamin D turnover or signalling pathway.
###end p 2
###begin p 3
###xml 34 35 34 35 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 62 63 62 63 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 65 66 65 66 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
Serum levels of calcidiol (25-OH-D3) and calcitriol (1,25-(OH)2-D3) were retrospectively assessed in 872 partipants of the German Asthma Family Study. 96 DNA single base variants in 13 different genes were genotyped with MALDI-TOF and a bead array system. At least one positive SNP with a TDT of p < 0.05 for asthma or total IgE and calcidiol or calcitriol was seen in IL10, GC, IL12B, CYP2R1, IL4R, and CYP24A1. Consistent strong genotypic association could not be observed. Haplotype association were found only for CYP24A1, the main calcidiol degrading enzyme, where a frequent 5-point-haplotype was associated with asthma (p = 0,00063), total IgE (p = 0,0014), calcidiol (p = 0,0043) and calcitriol (p = 0,0046).
###end p 3
###begin p 4
Genetic analysis of biological pathways seem to be a promising approach where this may be a first entry point into effects of a polygenic inherited vitamin D sensitivity that may affect also other metabolic, immunological and cancerous diseases.
###end p 4
###begin title 5
Background
###end title 5
###begin p 6
###xml 142 143 142 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 394 395 394 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 459 460 459 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 461 462 461 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 444 449 <span type="species:ncbi:9606">human</span>
Asthma is a chronic inflammatory condition of the airways, variable airway obstruction and elevated serum IgE levels of unclear pathogenesis [1]. A hypothesis relating early vitamin D supplementation and induction of later allergy has initially been postulated as the main cholecalciferol metabolite calcitriol may suppresses dendritic cell maturation and consecutive development of Th1 cells [2] which is now supported by in vitro, animal and human studies [3,4].
###end p 6
###begin p 7
###xml 183 184 183 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 185 186 185 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 501 502 501 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 20 26 <span type="species:ncbi:9606">humans</span>
Exposure studies in humans, however, are difficult as nearly all newborns in Western countries are now being exposed in utero or during the first year of life to vitamin supplements [5,6]. We now asked if there are DNA sequence variants that are associated with higher or lower levels of vitamin D metabolites. As it is unlikely that any complex disease is determined by variants in a single gene we tested the main genes that code for enzymes in the metabolic pathway of vitamin D conversion (Figure 1).
###end p 7
###begin p 8
Pathway diagram of genes tested for association.
###end p 8
###begin title 9
Methods
###end title 9
###begin title 10
Study population
###end title 10
###begin p 11
###xml 149 150 149 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 151 152 151 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 186 194 <span type="species:ncbi:9606">children</span>
###xml 286 294 <span type="species:ncbi:9606">children</span>
###xml 370 378 <span type="species:ncbi:9606">children</span>
###xml 618 629 <span type="species:ncbi:9606">participant</span>
The German Asthma Family Study collected affected sib pairs in 26 paediatric centres in Germany and Sweden for a two-stage genome-wide linkage scan [7,8]. In these families at least two children were required with confirmed clinical asthma, while prematurity or low birth weight of the children were excluded, along with any other severe pulmonary disease. All affected children over age 3 had a history of at least 3 years of recurrent wheezing and with no other airway disease diagnosed. Unaffected siblings were also sampled if they were at least 6 years old and eligible for pulmonary function testing. Each study participant signed a consent form. All study methods were approved by the ethics commission of "Arztekammer Nordrhein-Westfalen".
###end p 11
###begin p 12
###xml 346 347 346 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 348 349 348 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 90 102 <span type="species:ncbi:9606">Participants</span>
A complete pedigree of the family was drawn and information collected in a questionnaire. Participants were examined for several closely associated phenotypes. Pulmonary function tests were performed by forced flow volume tests and bronchial challenge was done by methacholine (discontinued in the second stage of the study) as reported earlier [7,8].
###end p 12
###begin p 13
###xml 57 58 57 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 59 60 59 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 248 250 248 250 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 310 311 310 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 289 301 <span type="species:ncbi:9606">participants</span>
The current analysis differs from previous publications [7,8]. We excluded here all families with at least one member of non white skin colour (families 2, 14, 16, 19 to 21 and 27 to 32) as these individuals had considerable lower levels of 25-OH-D3 (data not shown) compared to all other participants (Figure 2).
###end p 13
###begin p 14
###xml 39 41 39 41 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 61 73 <span type="species:ncbi:9606">participants</span>
Median, quartile and outlier of 25-OH-D3 serum levels in 872 participants of the German Asthma Family Study with white skin colour by month of examination.
###end p 14
###begin p 15
###xml 88 90 88 90 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 350 352 350 352 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 383 385 383 385 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 426 428 426 428 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 655 656 655 656 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 658 660 658 660 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 694 695 694 695 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 704 706 704 706 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 849 850 849 850 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 852 853 852 853 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
Total IgE was determined with an ELISA (Pharmacia Diagnostics, Uppsala, Sweden). 25-OH-D3 was determined with an enzymatic immunoassay (OCTEIA 25-Hydroxy Vitamin D kit, Immunodiagnostic Systems IDS, Frankfurt, Germany) that has a working range of 6-360 nmol/L, an intra-assay of 8% and inter-assay variation of 10% with a 100% specificity for 25-OH-D3 and 75% specificity for 25-OH-D2 according to the manufacturer. 1,25-OH2-D3 was determined by immunoextraction followed by an enzyme-immunoassay (OCTEIA 1,25-Hydroxy Vitamin D kit, Immunodiagnostic Systems IDS, Frankfurt, Germany) that has a working range of 6-500 pmol/L, a 100% specificity for 1,25-OH2-D3 and 0,009% specificity for 25-OH-D2. 25-OH-D3 values reported are the mean of a duplicate analysis while due to limited serum availability only single assays have been performed for 1,25-OH2-D3.
###end p 15
###begin title 16
Control population
###end title 16
###begin p 17
###xml 68 69 68 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
191 anonymized DNAs were selected randomly from the ECRHS II study [9] to fill in remaining slots on the genotyping plates. These DNA samples served as population-based controls to test if the parents of the famillies had different allele spectrum.
###end p 17
###begin title 18
DNA preparation and genotyping
###end title 18
###begin p 19
DNA was isolated from peripheral white blood cells using Qiamp (Qiagen, Germany) or Puregene isolation kits (Gentra Systems, Minneapolis, MN, USA).
###end p 19
###begin p 20
###xml 134 136 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 543 545 543 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 557 559 557 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
Genes were selected as coding either for key enzymes in the vitamin D conversion pathway or being regulated by vitamin D metabolites [10]. SNPs were being picked more or less randomly either for tagging haplotypes or being functional relevant [11]. Most SNPs were genotyped using MALDI-TOF mass spectrometry of allele-specific primer extension products generated from amplified DNA sequences (MassARRAY, SEQUENOM Inc., San Diego, CA, USA). A few SNPs were also genotyped at Illumina (San Diego CA, USA) by use of the Sentrix bead arrays. VDR [12] and IL4R [13] SNP results have been published earlier and are reanalysed here for the vitamin D levels. The following SNPs were analyzed (genotyping details upon request): rs3024498 (IL10), rs3024493 (IL10), rs1518111 (IL10), rs10000076 (IL10), rs1800872 (IL10), Il10-571CA (IL10), rs1800895 (IL10), rs1800894 (IL10), rs1800896 (IL10), rs1800893 (IL10), rs705120 (GC), rs222040 (GC), rs7041 (GC), rs4752 (GC), rs222011 (GC), rs221999 (GC), rs6811536 (SPP1), rs4754 (SPP1), rs1042714 (ADRB2), rs1800888 (ADRB2), rs1368439 (IL12B), rs3212227 (IL12B), rs2853697 (IL12B), rs3213119 (IL12B), rs2853696 (IL12B), rs2853694 (IL12B), rs2288831 (IL12B), rs3213096 (IL12B), rs2569254 (IL12B), rs3181216 (IL12B), rs3212220 (IL12B), rs3212218 (IL12B), rs1433048 (IL12B), rs2546890 (IL12B), rs3132299 (RXRA), rs877954 (RXRA), rs1045570 (RXRA), rs10500804 (CYP2R1), rs1562902 (CYP2R1), rs10766197 (CYP2R1), rs2853563 (VDR), rs731236 (VDR), rs7975232 (VDR), rs1544410 (VDR), rs2239185 (VDR), rs987849 (VDR), rs1540339 (VDR), rs3819545 (VDR), rs3782905 (VDR), rs2239186 (VDR), rs2228570 (VDR), rs1989969 (VDR), rs2853564 (VDR), hCV2880804 (VDR), rs238532 (CYP27B1), rs2072052 (CYP27B1), rs1048691 (CYP27B1), rs4646537 (CYP27B1), rs4646536 (CYP27B1), rs8176345 (CYP24A1), rs703842 (CYP27B1), I50V (IL4R), rs2234897 (IL4R), rs1805011 (IL4R), C406R (IL4R), rs1805015 (IL4R), Q551R (IL4R), rs1805016 (IL4R), rs10000306 (CARD15), rs2076753 (CARD15), rs2066842 (CARD15), rs2066843 (CARD15), rs2076756 (CARD15), rs10000331 (CARD15), rs3135499 (CARD15), rs3135500 (CARD15), rs375947 (IL12RB1), rs447009 (IL12RB1), rs436857 (IL12RB1), rs2045387 (IL12RB1), rs8118441 (CYP24A1), rs751089 (CYP24A1), rs6068816 (CYP24A1), rs4809958 (CYP24A1), rs2244719 (CYP24A1), rs2296241 (CYP24A1), rs17219266 (CYP24A1), rs6022999 (CYP24A1), rs17219315 (CYP24A1), rs11699278 (CYP24A1), rs2762942 (CYP24A1), rs2248137 (CYP24A1), rs2762943 (CYP24A1), rs2585427 (CYP24A1), rs2248359 (CYP24A1) and rs2426496 (CYP24A1).
###end p 20
###begin title 21
Data handling and statistical analysis
###end title 21
###begin p 22
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 267 269 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 397 399 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 564 566 564 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
Clinical data and genotypes were all transferred to a SQL 2000 database and checked for completeness, paternity, and Hardy-Weinberg equilibrium. Further analyses were performed using R 2.0 statistical software[14]. Linkage disequilibrium was determined by Haploview [15] using the Gabriel method for block definition. TDT association for quantitative and qualitative traits was done with SIBPAIR [16] using the TDT option for qualitative and the Haseman-Elston regression for quantitative traits. Family-based haplotype association analysis was performed by FBAT [17] using a dominant model.
###end p 22
###begin title 23
Bioinformatics
###end title 23
###begin p 24
###xml 41 43 41 43 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 225 227 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 236 238 236 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 263 265 263 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
SNP information was obtained from dbSNP [18], Innate Immunity PGA [19] and UCSC genome browser [20]. SNP selection was done with the help of Perlegen [21] and Hapmap [22] data. Sequence context annotation was done by SNPper [23], PUPA [24], TAMAL [25] and SNPPi [26]).
###end p 24
###begin title 25
Results
###end title 25
###begin p 26
###xml 103 104 103 104 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 118 119 118 119 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 121 123 121 123 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 296 297 296 297 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 311 312 311 312 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 314 316 314 316 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
The total sample consisted of 947 individuals from 224 families where 872 serum measurements of 25-OH-D3, 876 1,25- OH2-D3 and 934 total IgE measurements could be performed. After exclusion of non-white families 903 individuals from 201 families remained under analysis with 812 assays of 25-OH-D3, 807 1,25- OH2-D3 and 903 total IgE.
###end p 26
###begin p 27
###xml 52 53 52 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 228 229 228 229 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 231 233 231 233 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 78 86 <span type="species:ncbi:9606">children</span>
###xml 236 244 <span type="species:ncbi:9606">children</span>
###xml 421 429 <span type="species:ncbi:9606">children</span>
Clinical details of the families are given in table 1. Mean 25-OH-D3 level in children was 68 nmol/l (s.d. 38 nmol/l). 50% of values fell below and 17% above the Merck manual reference range of 62.4 to 99.8 nmol/l. Mean 1,25- OH2-D3 in children was 102 pmol/l (s.d. 38 nmol/l). 3% of values fell below and 40% above the Merck manual reference range of 48.4 to 108 pmol/l. The highest measured value was 257 pmol/l in two children from unrelated families.
###end p 27
###begin p 28
Clinical characteristics of the included 210 families of the German Asthma Family
###end p 28
###begin p 29
###xml 250 251 250 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 314 316 314 316 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 406 407 406 407 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 409 411 409 411 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 515 517 515 517 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 525 526 525 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 56 64 <span type="species:ncbi:9606">children</span>
There were no major differences in serum levels between children and parents. There was also no major influence by sex or age. An important factor, however, was found with month of examination representing seasonal sun exposure in mid Europe (Figure 2). Even after serum storage of 10 years, the individual 25-OH-D3 levels followed a clear time course with a major peak in August. The hormonal form 1,25-OH2-D3 did not vary over the course of the year, as the conversion rate decreased with higher levels of 25-OH-D3 (Figure 3).
###end p 29
###begin p 30
###xml 20 21 20 21 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 23 24 23 24 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 73 75 73 75 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 85 97 <span type="species:ncbi:9606">participants</span>
D-ratio (log(1,25-OH2-D3) [pmol/l]/log(25-OH-D3) [nmol/l]) versus 25-OH-D3 in in 867 participants of the German Asthma Family Study with white skin colour.
###end p 30
###begin p 31
###xml 32 34 32 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 45 47 45 47 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 68 70 68 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 81 82 81 82 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 84 86 84 86 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 102 104 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 195 196 195 196 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 198 200 198 200 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
The overall heritability index H2 for 25-OH-D3 was 80.3% while the H2 for 1,25-OH2-D3 was only 30.0% [27]. There was neither an association of 25-OH-D3 and total IgE nor an association of 1,25-OH2-D3 and total IgE levels.
###end p 31
###begin p 32
13 genes were selected for genotyping (IL10, GC, SPP, ADRB2, IL12B, RXRA, CYP2R1, VDR, CYP27B1, IL4R, CARD15, IL12RB1, CYP24A1) and could be successfully completed for 96 SNPs. 4 of these SNPs were not in Hardy-Weinberg equilibrium: rs221999 (GC, P = 0,0299), rs10500804 (CYP2R1, P = 0,0498), rs10766197 (CYP2R1, P = 0,0100) and rs2248359 (CYP24A1, P = 0,0299). SNP rs221999 was also not in Hardy-Weinberg equilibrium in controls. The population-based controls showed similar allele frequencies compared to the family samples except for SNPs rs4754, rs2288831 and rs3819545.
###end p 32
###begin p 33
###xml 111 113 111 113 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 183 184 183 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 551 553 551 553 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 576 577 576 577 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 579 580 579 580 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
SNP allele transmission in 7 of the tested 13 genes showed a p-value of less than 0.05 when testing for 25-OH-D3 levels (IL10, GC, ADRB2, CYP2R1, IL4R, IL12RB1 and CYP24A1, see table 2) while only 3 showed transmission disequilibrium with 1,25-OH2-D3 (IL10, IL12B and CYP24A1). SNPs in 5 genes showed a p-value < 0.05 with asthma (IL10, IL12B, VDR, CARD15 and CYP24A1). Most significances, however, were weak. For 96 SNPs we would expect 4.8 tests to be positive for each trait which was exceeded by testing asthma (N = 8), total IgE (N = 13), 25-OH-D3 (N = 8) but not 1,25-OH2-D3(N = 3). Only 2 SNP showed an effect with both traits, one in CYP2R1 (rs10766197) and one in IL4R (rs1805011). rs10766197 is situated in the CYP2R1 promotor; while rs1805011 is leading to an Ala- > Glu amino acid exchange in the IL4 receptor.
###end p 33
###begin p 34
Transmission approach: TDT results of 30 from 96 tested SNPs in 210 families of the German Asthma Family Study. Shown are only SNPs with at least one TDT results of p < 0.05. The underlined 11 SNPs also appear in table 3.
###end p 34
###begin p 35
###xml 138 139 138 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
In a next step we performed multivariate regression in the parental dataset while adjusting for age, sex, and month of examination (table 3). This confirmed 11 SNPs already found in the family based-aproach; again, association results were weak. Some CARD15 variants had an asthma protective effect while IL12B SNPs carried risk alleles.
###end p 35
###begin p 36
Case-control approach: Multivariate regression results of 31 from 96 tested SNPs in 408 parents of the German Asthma Family Study adjusted for age, sex and month of examination. Shown are only SNPs with at least one p < 0.05 for heterocygotes and homocygote carriers of the minor allele. The underlined 11 SNPs also appear in table 2.
###end p 36
###begin p 37
###xml 73 74 73 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 362 363 362 363 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 365 367 365 367 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 390 391 390 391 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 393 395 393 395 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 425 426 425 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
Haplotypes were constructed from all significantly associated SNPs (table2). No significant association was found in any of the 13 genes except for CYP24A1 where a 5-point frequent haplotype (rs2296241:rs17219315:rs2762942:rs2248137:rs2248359) spanning both LD blocks of CYP24A1 was associated with a diagnosis of asthma (p = 0.001), total IgE (p = 0.001), 25-OH2-D3 (p = 0.004) and 1,25-OH2-D3 serum level (p = 0.005, table 4).
###end p 37
###begin p 38
CYP24A1 haplotype transmission results in 213 families of the German Asthma Family Study. Haplotype was formed from all SNPs with p < 0.05 in the TDT (table 2).
###end p 38
###begin title 39
Discussion
###end title 39
###begin p 40
###xml 32 34 32 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 207 208 207 208 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 210 212 210 212 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
We have shown that serum 25-OH-D3 (calcidiol) levels -although highly influenced by environmental sunlight exposure- is a heritable trait in asthma families. In contrast, a major genetic influence on 1,25-OH2-D3 (calcitriol) levels could not be found, a finding that requires replication in further family and population-based studies.
###end p 40
###begin p 41
###xml 79 81 79 81 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 91 92 91 92 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 94 96 94 96 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 189 191 189 191 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 235 237 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 343 345 343 345 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 395 397 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 348 356 <span type="species:ncbi:9606">children</span>
The reason for this discrepancy is not fully clear as the conversion of 25-OH-D3 to 1,25-OH2-D3 is closely regulated by a direct feedback loop. It is generally agreed, however, that 25-OH-D3 reflects best the current vitamin D status [28]. Unfortunately standardized reference values for this age group are not available but values for 25-OH-D3 in children seem to be in the upper normal range [29]. An explanation therefore could be that a delayed downstream metabolism is leading to an (unintended) afflux or -also possible- that an increased peripheral demand needs a larger reservoir.
###end p 41
###begin p 42
We observed a number of positive associations with single nucleotide polymorphisms. Although the selection of candidate genes was rather subjective, it turned out that some of the tested candidate genes are associated with both allergy and vitamin D metabolites. Statistical significance, however, was weak, and varied even with different analysis strategies and software packages (unpublished own observation). There was also no fully consistent pattern when comparing the family transmission and the case-control approach which makes it unlikely that any of the tested SNPs is already an important functional variant. The new associations may instead indicate the effects of physically closely related variants in these genes (which is also supported by the haplotype results of CYP24A1).
###end p 42
###begin p 43
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 427 429 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 711 713 711 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 191 195 <span type="species:ncbi:10116">rats</span>
###xml 250 254 <span type="species:ncbi:10090">mice</span>
The associated candidate genes are of particular interest. CYP24A1 is the major enzyme of the calcitriol degradation pathway that showed nearly 100-fold increase after vitamin D treatment of rats [30]. Previous studies also suggest that CYP24A1 null mice cannot clear calcitriol efficiently [31] which would support the above mentioned afflux hypothesis. An alternative splicing variant in CYP24A1 has been described recently [32] leading to a truncated and catalytically dysfunctional protein while it is unclear if any of our tested SNPs will have functional relationship to this protein variant. Dark skinned Asian Indians seem to have increased 24-hydroxylase activity compared to white skinned Caucasians [33] whereas both skin colour and metabolic capacity seem to be adapted to less sun light exposure in Caucasians.
###end p 43
###begin p 44
###xml 83 85 83 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 418 420 414 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 22 27 <span type="species:ncbi:9606">human</span>
The evidence that the human CYP2R1 is a key vitamin D 25-hydoxylase is rather new [34] where the identity of the hepatic 25-hydroxylase has remained unclear for several decades. At least six CYPs can catalyze this step where the most viable candidates are CYP27A1 and CYP2R1 [34] with the renal enzyme responsible for 1-alpha-hydroxylation being CYP27B1. A loss of function mutation in CYP2R1 has also been described [34] and deserves further testing.
###end p 44
###begin p 45
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 274 276 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 290 292 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 314 316 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 326 328 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 338 340 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 365 367 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
Variants in CYP2R1, CYP27B1 and CYP24A1 or other genes in the metabolic pathway of vitamin D have not been tested so far with asthma or allergy but several of the VDR-controlled genes tested here already have been associated with asthma and allergy. These include IL12B [35-37], IL12RB [38,39], IL10 [40], VDR [41,42,12], GC [43], ADRB2 [44], CARD15 [45] and IL4R [46].
###end p 45
###begin p 46
###xml 210 212 210 212 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 407 409 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 578 580 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 629 634 <span type="species:ncbi:9606">human</span>
Of these, IL12B is a particular interesting cytokines. Macrophage engulfed microorganism are leading to IL12p70 production, a heterodimer of IL12p40 (IL12B) and IL12p35 (IL12A), which is a primary inducer of Th1 cell development and a critical factor in the development of allergy [47]. Also IL10 seems to be important where production in circulating T cells from atopic asthmatics is maximally stimulated [48]; allergen specific IL10 producing T regulatory cells can inhibit allergen specific effector cells and represent an important line of defense in the allergic reaction [49]. Functional variants in these genes leading to human disease are not known so far.
###end p 46
###begin p 47
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 496 498 496 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
The many positive but weak associations represent a common dilemma in complex disease. In asthma more than 75 genes have now been claimed to be associated [50] but none of them has been shown to contribute to risk in all populations studied [51]. Obviously there are only small genetic effects and a large heterogeneity; sometimes there is unidentified population stratification and there might be phenotyping and genotyping errors. Most likely, however, not the "center" SNPs have been choosen [11]. The current pathway based approach seems to be an alternative in particular when an environmental trait can be included. It is likely that some of the genes identified here are acting in concert to determine the overall vitamin D sensitivity.
###end p 47
###begin p 48
###xml 290 292 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
Besides increasing sample size and testing additional populations, further work may concentrate on monitoring vitamin D supplementation by immunological readouts and the identification of contributing functional genetic elements. The present rediscovery of a genetic vitamin D sensitivity [52] may be an important step in allergy induction and also surmount many other diseases including type 1 diabetes, osteoporosis, tuberculosis, rheumatoid arthritis, multiple sclerosis, inflammatory bowel diseases, and prostate cancer where adequate vitamin D support has been found to be beneficial.
###end p 48
###begin title 49
Abbreviations
###end title 49
###begin p 50
SNP = single nucleotide polymorphism
###end p 50
###begin p 51
###xml 1 3 1 3 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
D3 = cholecalciferol, vitamin D
###end p 51
###begin p 52
###xml 7 9 7 9 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
25-OH-D3 = calcidiol
###end p 52
###begin p 53
###xml 7 8 7 8 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 10 12 10 12 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
1,25-OH2-D3 = calcitriol
###end p 53
###begin p 54
CYP24A1 = cytochrome P450, family 24, subfamily A, polypeptide 1
###end p 54
###begin p 55
VDR = nuclear vitamin D receptor
###end p 55
###begin p 56
IL12B = interleukin 12 B (cytotoxic lymphocyte maturation factor 2, p40)
###end p 56
###begin p 57
RXRA = retinoid X receptor alpha
###end p 57
###begin p 58
IL4R = interleukin 4 receptor
###end p 58
###begin p 59
ADRB2 = ss2 adrenergic receptor
###end p 59
###begin p 60
IL12RB1 = interleukin 12 receptor, ss1
###end p 60
###begin p 61
IL10 = interleukin 10
###end p 61
###begin p 62
GC = group-specific component (vitamin D binding protein)
###end p 62
###begin p 63
CYP2R1 = cytochrome P450, family 2, subfamily R, polypeptide 1
###end p 63
###begin p 64
CARD15 = caspase recruitment domain family, member 15 (NOD2)
###end p 64
###begin p 65
SPP1 = secreted phosphoprotein 1, osteopontin (OPN, ETA-1, BNSP,...)
###end p 65
###begin p 66
CYP27B1 = cytochrome P450, family 27, subfamily B, polypeptide 1
###end p 66
###begin title 67
Authors' contributions
###end title 67
###begin p 68
M.W. initiated the study, applied for funding, developed protocols, trained investigators, planned laboratory analysis, did statistical analysis and wrote the report. J.A. did the clinical survey, C.B. did the SNP analysis, M.B. built serum and DNA bank and did the vitamin D assays together with E.A. who supervised also laboratory work and did functional assays. T.F-K. participated in the data analysis. All authors critically revised the paper.
###end p 68
###begin title 69
Conflicts of Interest
###end title 69
###begin p 70
The author(s) declare that they have no competing interests.
###end p 70
###begin p 71
Genomic organization of CYP24A1 gene, location of genotyped SNPs, linkage disequilibrium between SNPs (with R2 indicated by bullet size) and LD block structure (highlighted by red boxes; rs2248359 was excluded from LD calculations for not being in HWE). SNPs indicated by paragraph sign were used to build haplotypes.
###end p 71
###begin title 72
Acknowledgements
###end title 72
###begin p 73
We thank the participating families and clinical centers for their help: R. Nickel, K. Beyer, R. Kehrt, U.Wahn (Berlin), K. Richter, H. Janiki, R. Joerres, H. Magnussen (Grosshansdorf), I. M. Sandberg, L. Lindell, N.I.M. Kjellman (Linkoeping), C. Frye, G. Woehlke, I. Meyer, O. Manuwald (Erfurt), A. Demirsoy, M. Griese, D. Reinhardt (Munchen), G. Oepen, A. Martin, A. von Berg, D. Berdel (Wesel), Y. Guesewell, M. Gappa, H. von der Hardt (Hannover), J. Tuecke, F. Riedel (Bochum), M. Boehle, G. Kusenbach [+], H. Jellouschek, M. Barker, G. Heimann (Aachen), S. van Koningsbruggen, E. Rietschel (Koln), P. Schoberth (Koln), G. Damm, R. Szczepanski, T. Lob-Corzilius (Osnabruck), L. Schmid, W. Dorsch (Munchen), M. Skiba, C.Seidel, M. Silbermann (Berlin), A. Schuster (Dusseldorf), J. Seidenberg (Oldenburg), W. Leupold, J. Kelber (Dresden), W. Wahlen (Homburg), F. Friedrichs, K. Zima (Aachen), P. Wolff (Pfullendorf), D. Bulle (Ravensburg), W. Rebien, A.Keller (Hamburg) and M. Tiedgen (Hamburg). M. Hoeltzenbein organized the first part of the study, G. Schlenvoigt and L.Jaeger did the IgE determination and G. Fischer supervised data entry. T. Illig (former T.Immervoll), P. Lichtner and J. Heinrich supported the project during various stages; B. Wunderlich for excellent laboratory work during set up of the family study. We wish to thank also Amelie Elsaesser for programming the Jonkheere-Terpstra trend test and Michelle Emfinger for proof-reading of the manuscript.
###end p 73
###begin article-title 74
The role of allergy in the development of asthma
###end article-title 74
###begin article-title 75
Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes
###end article-title 75
###begin article-title 76
Genes, factor X, and allergens: what causes allergic diseases?
###end article-title 76
###begin article-title 77
The triple T allergy hypothesis
###end article-title 77
###begin article-title 78
Vitamin D supplementation in infancy and the risk of allergies in adulthood: a birth cohort study
###end article-title 78
###begin article-title 79
###xml 6 12 <span type="species:ncbi:9606">infant</span>
Early infant multivitamin supplementation is associated with increased risk for food allergy and asthma
###end article-title 79
###begin article-title 80
A genome-wide search for linkage to asthma. German Asthma Genetics Group
###end article-title 80
###begin article-title 81
Phenotypic and genetic heterogeneity in a genome-wide linkage study of asthma families
###end article-title 81
###begin article-title 82
TLR4 gene variants modify endotoxin effects on asthma
###end article-title 82
###begin article-title 83
Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes
###end article-title 83
###begin article-title 84
Target SNP selection in complex disease association studies
###end article-title 84
###begin article-title 85
Genetic variants in the vitamin D receptor and childhood asthma
###end article-title 85
###begin article-title 86
Asthma and IL-4 receptor alpha gene variants
###end article-title 86
###begin article-title 87
Rproject
###end article-title 87
###begin article-title 88
Haploview
###end article-title 88
###begin article-title 89
Sibpair
###end article-title 89
###begin article-title 90
FBAT
###end article-title 90
###begin article-title 91
dbSNP
###end article-title 91
###begin article-title 92
PGA II
###end article-title 92
###begin article-title 93
Browser UG
###end article-title 93
###begin article-title 94
Perlegen
###end article-title 94
###begin article-title 95
Hapmap
###end article-title 95
###begin article-title 96
SNPper
###end article-title 96
###begin article-title 97
PUPA
###end article-title 97
###begin article-title 98
TAMAL
###end article-title 98
###begin article-title 99
SNPPI
###end article-title 99
###begin article-title 100
Maternal vitamin D status and childhood bone mass
###end article-title 100
###begin article-title 101
Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety
###end article-title 101
###begin article-title 102
###xml 48 56 <span type="species:ncbi:9606">children</span>
Vitamin D status of chronically ill or disabled children in Victoria
###end article-title 102
###begin article-title 103
###xml 28 31 <span type="species:ncbi:10116">rat</span>
Gene expression profiles in rat intestine identify pathways for 1,25-dihydroxyvitamin D(3) stimulated calcium absorption and clarify its immunomodulatory properties
###end article-title 103
###begin article-title 104
###xml 165 170 <span type="species:ncbi:10090">mouse</span>
Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse
###end article-title 104
###begin article-title 105
Alternative splicing of vitamin D-24-hydroxylase: a novel mechanism for the regulation of extrarenal 1,25-dihydroxyvitamin D synthesis
###end article-title 105
###begin article-title 106
Vitamin D metabolism is altered in Asian Indians in the southern United States: a clinical research center study
###end article-title 106
###begin article-title 107
###xml 26 31 <span type="species:ncbi:9606">human</span>
Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase
###end article-title 107
###begin article-title 108
The IL12B gene is associated with asthma
###end article-title 108
###begin article-title 109
###xml 92 100 <span type="species:ncbi:9606">children</span>
Association of IL12B promoter polymorphism with severity of atopic and non-atopic asthma in children
###end article-title 109
###begin article-title 110
Functional haplotypes of IL-12B are associated with childhood atopic asthma
###end article-title 110
###begin article-title 111
Association study between interleukin-12 receptor beta1/beta2 genes and type 1 diabetes or asthma in the Japanese population
###end article-title 111
###begin article-title 112
Association of the IL12RB1 promoter polymorphisms with increased risk of atopic dermatitis and other allergic phenotypes
###end article-title 112
###begin article-title 113
###xml 65 73 <span type="species:ncbi:9606">children</span>
IL10 gene polymorphisms are associated with asthma phenotypes in children
###end article-title 113
###begin article-title 114
Association of vitamin D receptor genetic variants with susceptibility to asthma and atopy
###end article-title 114
###begin article-title 115
Association of vitamin D receptor gene polymorphisms with childhood and adult asthma
###end article-title 115
###begin article-title 116
Association of vitamin D binding protein variants with chronic mucus hypersecretion in Iceland
###end article-title 116
###begin article-title 117
The glutamine 27 beta2-adrenoceptor polymorphism is associated with elevated IgE levels in asthmatic families
###end article-title 117
###begin article-title 118
Association of CARD15 polymorphisms with atopy-related traits in a population-based cohort of Caucasian adults
###end article-title 118
###begin article-title 119
Ile50Val variant of IL4R alpha upregulates IgE synthesis and associates with atopic asthma
###end article-title 119
###begin article-title 120
Different profiles of T-cell IFN-gamma and IL-12 in allergen-induced early and dual responders with asthma
###end article-title 120
###begin article-title 121
Different profile of interleukin-10 production in circulating T cells from atopic asthmatics compared with healthy subjects
###end article-title 121
###begin article-title 122
T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases
###end article-title 122
###begin article-title 123
Asthma genetics 2006: the long and winding road to gene discovery
###end article-title 123
###begin article-title 124
Rethinking genetic models of asthma: the role of environmental modifiers
###end article-title 124
###begin article-title 125
Uberempfindlichkeit gegen Vitamin D
###end article-title 125

